Vaishali J. Patel

FDA investigator

Appears on 8 documents from 2019 to 2026, most often at sites in India. Most often cites written procedures; deviations (21 CFR 211.100).

8
Documents on file
4.9
Observations per 483
2019
First seen
2026
Most recent

What they cite most

From 39 observations

Activity by year

2019: 1, 2022: 2, 2024: 2, 2025: 2, 2026: 1

Where

India 2 · California 1 · Indiana 1 · Kansas 1 · Minnesota 1 · Ohio 1

Is Vaishali J. Patel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

8 documents, newest first
FirmOpen
483 Ve t erinary Pharmacy CorporationMar 19, 2026 · Saint Peter, Minnesota
483 Rebel Converting, LLCFeb 24, 2025 · Milwaukee, Wisconsin
483 Clinical Resolution Laboratory, Inc.Jan 16, 2025 · Brea, California
483 EUGIA Pharma Specialities LimitedMay 3, 2024 · Bhiwadi, India
483 Lupin LtdMar 15, 2024 · Aurangabad, India
483 Xellia Pharmaceuticals USA LLCDec 15, 2022 · Bedford, Ohio
483 ITW Pro BrandsApr 1, 2022 · Olathe, Kansas

About this profile

What does Vaishali J. Patel inspect?

Vaishali J. Patel appears on 8 documents on file covering 8 sites, most often in India.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Vaishali J. Patel is dated Mar 19, 2026.